UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000002532 |
|---|---|
| Receipt number | R000003094 |
| Scientific Title | Double blinded randomized placebo controlled trial to examine if intake of vitamin D supplement can prevent INFLUENZA PANDEMIC (H1N1) 2009 targeting on high school students |
| Date of disclosure of the study information | 2009/10/17 |
| Last modified on | 2009/12/21 16:58:01 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Double blinded randomized placebo controlled trial to examine if intake of vitamin D supplement can prevent INFLUENZA PANDEMIC (H1N1) 2009 targeting on high school students
Acronym
Amateras IX
Scientific Title
Double blinded randomized placebo controlled trial to examine if intake of vitamin D supplement can prevent INFLUENZA PANDEMIC (H1N1) 2009 targeting on high school students
Scientific Title:Acronym
Amateras IX
Region
| Japan |
Condition
Condition
Influenza Pandemic (H1N1) 2009 Virus
Classification by specialty
| Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We will determine if vitamin D3 peroral administration of 2000IU/day for 9 weeks can prevent incidence of INFLUENZA PANDEMIC (H1N1) 2009 diagnosed by medical doctors, and upper and lower respiratory symptoms, by conducting a double blind randomized controlled clinical trial and by targeting high school students.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
doctor diagnosed influenza A
Key secondary outcomes
upper and lower respiratory symptoms
School absent days
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
NO
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
YES
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
vitamin D3
Interventions/Control_2
placebo
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 15 | years-old | <= |
Age-upper limit
| 18 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1. Both the subject and guardian agreed to participate in the trial with written form of consent
2. Nothing correspond to excluding criteria
Key exclusion criteria
1. Person who was already infected with Influenza Pandemic (H1N1) 2009 Virus
2. Person who has past history of urinary tract stone
3. Person who has chronic disease and taking any medication for more than one month
4. Person who is taking vitamin D supplement
5. Person who has serious allergy
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Mitsuyoshi Urashima |
Organization
Jikei University School of Medicine
Division name
Division of Molecular Epidemiology
Zip code
Address
3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, 1058461 JAPAN
TEL
03-3433-1111
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Emi Suzuki |
Organization
Jikei University School of Medicine
Division name
Division of Molecular Epidemiology
Zip code
Address
TEL
Homepage URL
emisuzu@jikei.ac.jp
Sponsor or person
Institute
Jikei University School of Medicine
Division of Molecular Epidemiology
Institute
Department
Personal name
Funding Source
Organization
Jikei University School of Medicine
Division of Molecular Epidemiology
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Seisoku High School
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2009 | Year | 10 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2009 | Year | 09 | Month | 18 | Day |
Date of IRB
Anticipated trial start date
| 2009 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2009 | Year | 12 | Month | 01 | Day |
Date of closure to data entry
| 2009 | Year | 12 | Month | 01 | Day |
Date trial data considered complete
| 2009 | Year | 12 | Month | 01 | Day |
Date analysis concluded
| 2010 | Year | 01 | Month | 01 | Day |
Other
Other related information
Management information
Registered date
| 2009 | Year | 09 | Month | 19 | Day |
Last modified on
| 2009 | Year | 12 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003094
